Aharon Schwartz - 03 Jan 2023 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Joseph R. Magnas, POA
Issuer symbol
PLX
Transactions as of
03 Jan 2023
Net transactions value
+$155,815
Form type
4
Filing time
05 Jan 2023, 16:08:38 UTC
Previous filing
09 Sep 2022
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Purchase $155,815 +110,000 +172% $1.42 174,000 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.430 to $1.405 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.